What triggered the shutdown of Afyren’s AFYREN NEOXY plant, and what was the outcome?

The AFYREN NEOXY plant in Clermont-Ferrand, France was shut down in June to implement technical changes aimed at boosting output of its fermentation process. The work was completed as planned and on budget at €6 million, and production has since resumed. Afyren expects accelerated production in the second half of 2026, following a first semester in which revenue doubled compared with fiscal year 2025.

How does Afyren characterize its financial and operational performance in the first half of 2026?

Afyren reported that its first semester of 2026 saw revenue double compared with fiscal year 2025, and it anticipates an acceleration in production during the second half of 2026 following the successful completion of technical upgrades at its AFYREN NEOXY plant.

Afyren restarts bio-based carboxylic acids plant

Jul 9, 2026

Afyren resumed production at its French NEOXY plant after €6 million in technical upgrades to boost fermentation output. The company anticipates accelerated production in late 2026 and reported doubled revenue compared to fiscal year 2025.

chemweek

2026-07-09

Afyren restarts bio-based carboxylic acids plant

2026-11-06

Afyren, Minasolve Team Up on Biobased Fragrance Ingredients

Afyren restarts bio-based carboxylic acids plant

FAQ